Radiotherapy of tbc adenitis Ed. Wуs and A. Eghiауаr (Schweiz. Med. W., 1927, No. 49)
, 1928 openalex +2 more sources
Results of Treatment in Glomus Jugulare Tumors with Emphasis on Radiotherapy [PDF]
, 1962 J. D. R. Miller
openalex +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Molecular Oncology, EarlyView.Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley +1 more source
Targeting the Enhanced Sensitivity of Radiotherapy in Cancer: Mechanisms, Applications, and Challenges. [PDF]
MedComm (2020)Zhao Y +5 more
europepmc +1 more source
To the radiotherapy of cervical cancers. Laborde (by Veg. ü. d. ges Gyn., Bd. XII)
, 1928 A. Timofeev
openalex +2 more sources
Role of intensive radiotherapy in the management of Hodgkin's disease [PDF]
, 1966 Henry S. Kaplan
openalex +1 more source
Molecular Oncology, EarlyView.Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen +12 more
wiley +1 more source
The impact of radiotherapy on the prognosis of metastatic clear cell renal cell carcinoma after surgery. [PDF]
Sci RepLi X +9 more
europepmc +1 more source
Radiotherapy in the treatment of sarcomas of the corpus uteri [PDF]
, 1969 Ahmed O. Badib +3 more
openalex +1 more source
Does Porphyromonas gingivalis truly inhibit the oral carcinogenesis?
Molecular Oncology, EarlyView.Chen‐xi Li, Zhong‐cheng Gong
wiley +1 more source